A patient taking levothyroxine 50 µg has a TSH of 18.2 mIU/L with low‑normal free T4; how should I adjust the levothyroxine dose and counsel her on proper administration?

Increase Levothyroxine to 75 mcg Daily and Recheck TSH in 6–8 Weeks

Your patient has uncontrolled primary hypothyroidism with a markedly elevated TSH of 18.2 mIU/L on levothyroxine 50 mcg daily—increase the dose to 75 mcg daily (a 25 mcg increment) and recheck TSH and free T4 in 6–8 weeks. 1, 2, 3

---

Why This Dose Adjustment Is Necessary

• TSH >10 mIU/L indicates inadequate replacement and carries approximately 5% annual risk of progression to symptomatic overt hypothyroidism, along with adverse cardiovascular and metabolic consequences including cardiac dysfunction, elevated LDL cholesterol, and reduced quality of life. 1
• Your patient's low-normal T4 (6.5) and FT4 index (1.6) confirm she is biochemically hypothyroid despite being on therapy, reflecting either under-replacement or nonadherence. 1
• Treatment at this TSH level is mandatory regardless of symptoms because the metabolic burden includes delayed myocardial relaxation, abnormal cardiac output, and dyslipidemia. 1

---

Recommended Dose Adjustment Strategy

Increment Size

• Increase by 25 mcg (from 50 mcg to 75 mcg daily) based on her current dose and the degree of TSH elevation. 1, 2
• This increment is appropriate for a patient under 70 years without cardiac disease—larger adjustments (25 mcg) are safe in younger patients, while smaller increments (12.5 mcg) are reserved for elderly or cardiac patients. 1

Timing of Reassessment

• Recheck TSH and free T4 in 6–8 weeks, the interval required for levothyroxine to reach steady-state concentrations. 1, 2, 3
• Adjusting doses more frequently risks inappropriate titration before steady state is achieved. 1

Target Range

• Aim for TSH 0.5–4.5 mIU/L with normal free T4 to restore euthyroidism and prevent both under-treatment and over-treatment complications. 1, 2

---

Critical Counseling on Proper Administration

Timing and Food Interactions

• Take levothyroxine on an empty stomach, 30–60 minutes before breakfast, with a full glass of water to optimize absorption and avoid choking. 3
• Food, especially high-fiber meals, significantly reduces levothyroxine absorption—fasting administration is non-negotiable. 3

Drug Interactions That Impair Absorption

• Separate levothyroxine from iron, calcium supplements, antacids, and proton-pump inhibitors by at least 4 hours because these agents chelate levothyroxine and reduce bioavailability by 30–50%. 1, 3
• If she takes any of these medications, verify the timing—concurrent administration is a common cause of persistent TSH elevation despite adequate dosing. 1

Adherence Assessment

• Nonadherence is the most common cause of elevated TSH in treated patients—directly ask about missed doses, timing inconsistencies, and whether she takes it with food or other medications. 1
• Consider a levothyroxine absorption test (10 mcg/kg or maximum 600 mcg) if malabsorption is suspected, though true malabsorption is rare; an increment in free T4 >0.40 ng/dL at 3 hours excludes malabsorption with 97% sensitivity. 4

---

Common Pitfalls to Avoid

Do Not Delay Treatment

• Never wait for repeat testing when both TSH and free T4 are clearly abnormal—overt hypothyroidism requires immediate dose adjustment, not watchful waiting. 2
• The 30–60% spontaneous normalization rate applies only to isolated mild TSH elevations (4.5–10 mIU/L) with normal free T4, not to overt hypothyroidism. 1

Avoid Overtreatment

• Approximately 25% of patients on levothyroxine are unintentionally over-replaced, leading to TSH suppression and increased risk of atrial fibrillation (3–5 fold), osteoporosis, and fractures. 1
• Monitor TSH and free T4 at every follow-up to prevent iatrogenic subclinical hyperthyroidism. 1

Rule Out Adrenal Insufficiency in Specific Contexts

• If central hypothyroidism or hypophysitis is suspected (e.g., pituitary disease, recent immunotherapy), rule out adrenal insufficiency before increasing levothyroxine because thyroid hormone accelerates cortisol metabolism and can precipitate adrenal crisis. 1, 2
• This patient has primary hypothyroidism (elevated TSH with low T4), so adrenal screening is not required unless she has unexplained hypotension, hyponatremia, or hyperpigmentation. 1

---

Long-Term Monitoring Plan

After Dose Stabilization

• Once TSH normalizes (0.5–4.5 mIU/L), recheck TSH every 6–12 months to ensure continued euthyroidism and detect dose drift. 1, 2
• Free T4 measurement is optional during maintenance but helpful if TSH remains borderline or symptoms persist. 1

If TSH Remains Elevated After Dose Increase

• If TSH is still >10 mIU/L after 6–8 weeks on 75 mcg, increase to 100 mcg daily and reassess again in 6–8 weeks. 1
• Persistent elevation despite escalating doses suggests nonadherence, malabsorption (rare), or drug interactions—address these systematically before further dose increases. 1

---

Patient Education Points

Symptom Improvement Timeline

• It may take 6–8 weeks to notice improvement in fatigue, weight, cold intolerance, and other hypothyroid symptoms because levothyroxine has a long half-life and requires time to reach steady state. 3
• Reassure her that symptom resolution lags behind biochemical normalization. 3

Lifelong Therapy

• Levothyroxine is lifelong replacement therapy for primary hypothyroidism—it replaces the hormone her thyroid gland no longer produces adequately. 3
• Discontinuation will result in recurrent hypothyroidism. 3

Pregnancy Considerations

• If she is planning pregnancy, notify you immediately because levothyroxine requirements increase by 25–50% during pregnancy, and untreated hypothyroidism increases risk of preeclampsia, low birth weight, and neurodevelopmental deficits in the child. 1
• Target TSH <2.5 mIU/L in the first trimester. 1